Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Pediatric Pulmonology|April 8, 2026
Characterization of Pulmonary Dysfunction in Systemic Juvenile Idiopathic Arthritis Using Xenon and Proton MRIWilliam J Garrison, Matthew M Willmering, Bilal I Masokano, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 16, 2020
On the Alert for Cytokine Storm: Immunopathology in COVID-19Lauren A Henderson, Scott W Canna, Grant S Schulert, et al.
Arthritis and Rheumatism|July 1, 2009
Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritisMichael G Barnes, Alexei A Grom, Susan D Thompson, et al.
Nature Immunology|May 21, 2021
Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiationPeggie Cheung, Steven Schaffert, Sarah E Chang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2023
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN VariantsRemco G A Erkens, Jorg J A Calis, Anouk Verwoerd, et al.
Arthritis Research & Therapy|January 25, 2017
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapyArndt H Brachat, Alexei A Grom, Nico Wulffraat, et al.
Annals of the Rheumatic Diseases|July 24, 2023
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 24, 2023
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)Bita Shakoory, Ashley Geerlinks, Marta Wilejto, et al.
Annals of the Rheumatic Diseases|September 24, 2024
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's diseaseBruno Fautrel, Stéphane Mitrovic, Arianna De Matteis, et al.
Pageof 9